As IP issues move up the political agenda IP owners and their lawyers have their biggest opportunity yet to influence the policy making process. Emma Barraclough and Eileen McDermott explain how to do it
Managing IP profiles some of the most heavily lobbied IP issues worldwide and considers how IP owners and activists shaped the debate - and the outcome
IP lobbying extends to more than just official policy making. Peter Ollier looks at how companies can ensure that their voice is heard during litigation in Asia
Japan may be about to lose its reputation as a difficult jurisdiction for owners of non-traditional trade marks. Hiromichi Aoki explains what progress has been made
Trade mark owners who want to stop other businesses from incorporating their marks into company names have a range of options open to them. Managing IP asked correspondents in six jurisdictions to outline the rules
Buying a brand from a company that is in financial trouble can be risky. But for purchasers who carry out proper due diligence, it can also be profitable. Sarah Anne Keefe explains how to do it in the US
A dated, stale trade mark may affect an IP owner's bottom line. Making the mark fluid may be a good solution but also entails risks under Benelux and Community law. Flip Petillion and Cedric Vanleenhove explain how to minimise them
Demand for patents over so-called green business methods is rising, just as standards of patent eligibility in the US have been significantly narrowed. Joseph Helmsen and Ritu Singh explain how to draft claims to meet the new test
From Venkatesh Hariharan, corporate affairs director, Red Hat
Our company launched a new product last year but we have since discovered that a leading supermarket is selling an own brand version that looks very similar. What should we do?
A monthly column devoted to IP curiosities and controversies, named in honour of John of Utynam - who received the world's first recorded patent in 1449
New IP round-up from @mdloney, featuring biosimilars complaint, SiriusXM ruling, ED of Tex filing slump and more! https://t.co/1szaMeR3j1
Our analysis of SCOTUS Life Tech v Promega ruling https://t.co/CL6Ibt23RO Court didn't indicate how many components enough for infringement
RT @PatentScholar: SCOTUS opinion in LifeTech v. Promega is out—supply of single component doesn't lead to §271(f)(1) liability https://t.c…
Top firms for trade marks 2017
Find out which firms are ranked in the first part of this year’s IP Stars research. Below, we provide a guide to the research and methodology
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2017 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International